| ||
Name: nilotinib | ||
Formula: C28 H22 F3 N7 O | ||
Weight: 529.516 | ||
SMILES: "Cc1cn(cn1)c2cc(NC(=O)c3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)cc(c2)C(F)(F)F" | ||
Spacial conformation based on PDB
3cs9. Also present on 3gp0, 5mo4 |
RESIDUE NIL 61 CONECT O17 1 C16 CONECT C16 3 O17 N14 C18 CONECT N14 3 C16 C11 HN14 CONECT C11 3 N14 C9 C12 CONECT C9 3 C11 C8 H9 CONECT C8 3 C9 N51 C6 CONECT N51 3 C8 C56 C52 CONECT C56 3 N51 C55 H56 CONECT C55 3 C56 C58 N54 CONECT C58 4 C55 H58 H58A H58B CONECT N54 2 C55 C52 CONECT C52 3 N51 N54 H52 CONECT C6 3 C8 C5 H6 CONECT C12 3 C11 C5 H12 CONECT C5 3 C6 C12 C2 CONECT C2 4 C5 F4 F3 F1 CONECT F4 1 C2 CONECT F3 1 C2 CONECT F1 1 C2 CONECT C18 3 C16 C25 C19 CONECT C25 3 C18 C23 H25 CONECT C23 3 C25 C22 H23 CONECT C22 3 C23 C27 C21 CONECT C27 4 C22 H27 H27A H27B CONECT C21 3 C22 C19 N31 CONECT C19 3 C18 C21 H19 CONECT N31 3 C21 C33 HN31 CONECT C33 3 N31 N40 N34 CONECT N40 2 C33 C38 CONECT C38 3 N40 C36 H38 CONECT C36 3 C38 C35 H36 CONECT C35 3 C36 N34 C41 CONECT N34 2 C33 C35 CONECT C41 3 C35 C49 C42 CONECT C49 3 C41 C47 H49 CONECT C47 3 C49 C45 H47 CONECT C45 3 C47 N44 H45 CONECT N44 2 C45 C42 CONECT C42 3 C41 N44 H42 CONECT HN14 1 N14 CONECT H9 1 C9 CONECT H56 1 C56 CONECT H58 1 C58 CONECT H58A 1 C58 CONECT H58B 1 C58 CONECT H52 1 C52 CONECT H6 1 C6 CONECT H12 1 C12 CONECT H25 1 C25 CONECT H23 1 C23 CONECT H27 1 C27 CONECT H27A 1 C27 CONECT H27B 1 C27 CONECT H19 1 C19 CONECT HN31 1 N31 CONECT H38 1 C38 CONECT H36 1 C36 CONECT H49 1 C49 CONECT H47 1 C47 CONECT H45 1 C45 CONECT H42 1 C42 END HET NIL 61 HETSYN NIL 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluorom HETSYN 2 NIL ethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]be HETSYN 3 NIL nzamide HETNAM NIL Nilotinib FORMUL NIL C28 H22 F3 N7 O1
This OCA
MONOMER page uses Jmol, developed by the Jmol Development Team (color reference)
|